Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I guess

"Then there's the concept of a reverse merger of TPL (acquirer) into PTSC (lamb at slaughter) so that TPL becomes instantly 'public'."

Or, TPL acquring PTSC and takes them private. Pays us .08 a share, and it's done.

Dirty laundry forever hidden.

Like I said...cynical.

Share
New Message
Please login to post a reply